Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Serum lamivudine levels in the presence of a lamivudine-resistant HBV mutant.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver - 1 Oct 2004

Torre F, Mattioli F, Campo N, Delfino A, Basso M, Pelli N, Martelli A, Picciotto A

Abstract excerpt

BACKGROUND/AIMS: Lamivudine efficiently inhibits hepatitis B virus replication and has been used to treat hepatitis B virus recurrence after orthotopic liver transplantation. Although effective, its use is hampered by viral breakthrough due to the appearance of hepatitis B virus drug-resistant strains. Aims of this work were to evaluate the inter- and intra-individual variations of lamivudine serum levels and the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to Chromatography, High Pressure Liquid

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance, Viral

Share to Enzyme-Linked Immunosorbent Assay

Share to Hepatitis B

Share to Hepatitis B virus

Share to Lamivudine

Share to Recurrence

Source

Identifiers

PMID: 15506667
DOI: 10.1016/j.dld.2004.03.020

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Serum lamivudine levels in the presence of a lamivudine-resistant HBV mutant.PMID 15506667Read ↗

Transient emergence of hepatitis B variants in a patient with chronic hepatitis B resistant to lamivudine.Semantic proximity Read ↗

HBV mutations associated with lamivudine therapy.Semantic proximity Read ↗

Efficacy and tolerability of long-term therapy using high lamivudine doses for the treatment of chronic hepatitis B.Semantic proximity Read ↗

Lamivudine-resistance mutations can be selected even at very low levels of hepatitis B viraemia.Semantic proximity Read ↗

High rates of progressive hepatic functional deterioration whether lamivudine therapy is continued or discontinued after emergence of a lamivudine-resistant mutant: a prospective randomized controlled study.Semantic proximity Read ↗

Analysis of hepatitis B virus quasispecies changes during emergence and reversion of lamivudine resistance in liver transplantation.Semantic proximity Read ↗

HBV resistant to lamivudine: experimental and clinical studies.Semantic proximity Read ↗

Clinical course after stopping lamivudine in chronic hepatitis B patients with lamivudine-resistant mutants.Semantic proximity Read ↗

Hepatitis B virus genotypes and resistance mutations in patients under long term lamivudine therapy: characterization of genotype G in Brazil.Semantic proximity Read ↗

Potential and limitations of lamivudine monotherapy in chronic hepatitis B: evidence from genotyping.Semantic proximity Read ↗

[Evolution of hepatitis B virus quasispecies during antiviral therapy in one chronic hepatitis B patient].Semantic proximity Read ↗

Dynamics of Hepatitis B Virus Resistance to LamivudineSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.